ABSTRACT A cDNA library has been constructed from canine poly(A)+ mRNA. Clones containing cDNA inserts coding for prechymotrypsinogen 2 (isoelectric point = 7.1; Mr = 27,500), one of three canine pancreatic isoenzyme forms, were selected by colony hybridization using a cDNA probe synthesized from immunoselected prechymotrypsinogen 2 mRNA. To verify that cDNA clones code for prechymotrypsinogen 2 forms that translocate across rough endoplasmic reticulum membranes and fold into stable and identifiable secretory proteins, we conducted in vitro translation of hybrid-selected mRNA in the presence of microsomal membranes and optimal concentrations of glutathione and analyzed nascent translation products in their nonreduced state by two-dimensional isoelectric focusing/NaDodSO4 gel electrophoresis and fluorography. A near full-length chymotrypsinogen 2 cDNA and its primed extension were used to determine the nucleotide sequence for the entire coding region of prechymotrypsinogen 2 mRNA and 87 residues, including a poly(A) addition signal, in the 3' nontranslated region. The deduced amino acid sequence shows a 263-residue presecretory protein containing an 18-residue aminoterminal transport peptide (Met-Ala-Phe-Leu-Trp-Leu-Leu-SerCys-Phe-Ala-Leu-Leu-Gly-Thr-Ala-Phe-Gly), which we have previously shown to mediate the translocation of chymotrypsinogen 2 across the rough endoplasmic reticulum membrane. Following the transport peptide is a 245-residue proenzyme, which shows 82% and 80% sequence identity with bovine chymotrypsinogens A and B, respectively. Conserved among the three zymogens are 10 Cys residues that form five disulfide bonds in bovine chymotrypsinogens A and B and the residues that are required for zymogen activation, substrate binding, and catalytic activity.
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Chymotrypsin(ogen) (EC 3.4.21.1) is synthesized and secreted by the exocrine pancreas and, upon delivery to the intestinal tract, is activated by trypsin to form chymotrypsin, a proteolytic enzyme important in the digestive process. In the past 20 years chymotrypsinogen and chymotrypsin have represented prototype molecules for the study of (pro)enzyme structure and function. The complete amino acid sequence of bovine chymotrypsinogen A was determined by Hartley (1) and that for bovine chymotrypsinogen B by Smillie et al. (2) . X-ray crystallography structures of the zymogen (3) and the enzyme (4) were determined by Blow and collaborators. Scheele et al. (5) showed that chymotrypsinogen is synthesized as a presecretory protein containing an amino-terminal transport peptide responsible for translocation of the nascent protein across the membrane of the rough endoplasmic reticulum. The partial amino acid sequence of the transport peptide has been recently determined by Came and Scheele (6) .
In this study we have developed a strategy to correlate the coding potentials of individual cDNAs with specific isoenzymic forms containing topogenic signals responsible for protein translocation across the rough endoplasmic reticulum membrane and export from the cell. This strategy includes in vitro translation of hybridization-selected mRNA in a reticulocyte lysate protein-synthesizing system in the presence of nucleasetreated microsomal membranes from canine (dog) pancreas and optimal concentrations of glutathione (5, 7), separation of translation products by two-dimensional urea isoelectric focusing (IEF)/NaDodSO4 gel electrophoresis in the absence of reducing agents (7, 8) , and analysis of radioactive products by fluorography. Comigration of nascent proteins with mature secretory proteins under these conditions depends on a number of sequential and overlapping biochemical events: (i) microsomal membrane recognition of the translation product as a presecretory protein containing an amino-terminal transport peptide (or its equivalent); (ii) functional translocation of the nascent product across the microsomal membrane; (iii) proteolytic cleavage of the transport peptide; (iv) sequestration within the microsomal lumen; and (v) development of conformation, including formation of the correct set of disulfide bonds resulting in the formation of a stable protein soluble in the aqueous cisternal medium (7, 9) . Where studied, such pancreatic proteins (including chymotrypsinogen 2), synthesized and processed in vitro, have demonstrated biological and probiological activities (10) . The resulting isoelectric point (pI) and apparent molecular weight of the final product, as judged by migration on two-dimensional gels, indicate the precise exportable protein that is encoded by the cDNA. After selection of a cDNA clone coding for one of the three isoenzymic forms of canine chymotrypsinogen, we have determined the nucleotide sequence for the entire coding region of prechymotrypsinogen 2 mRNA and noncoding bases in the 3' flanking region.
METHODS
Construction of a Canine Pancreatic cDNA Library. Canine pancreatic RNA was extracted from a postnuclear supernate as described (5, 11) and poly(A)+ mRNA was isolated by chromatography on oligo(dT)-cellulose (12) . Double-stranded cDNA was synthesized (13) using the mixture of canine pancreas poly(A)+ mRNA and inserted into pUC9 plasmids (14) at the Pst I site by G-C tailing (15) . JM83 Escherichia coli were transformed with the pUC9 plasmid mixture by standard procedures (16) (22) . Identification ofcDNA-containing clones was verified by code analysis as follows: plasmid DNA (1.8 ,ug) isolated from bacterial colonies by alkaline NaDodSO4 extraction, purified on CsCl gradients, and bound to 3 x 3 mm nitrocellulose squares was used for hybrid selection of canine pancreaspoly(A)+mRNAasdescribedbyManiatisetal. (23) . Hybrid-selected mRNA was translated in vitro andradioactive products were separated in two-dimensional gels and analyzed as described in the text. (c) Translation products derived from mRNA hybridized to pC2-13, which was used to determine the nucleotide sequence ofcanine prechymotrypsinogen 2. Numbers on the upper abscissae indicate pIs. Numbers on the right ordinate indicate molecular weight values x 10-3 for nonreduced proteins. In a, the proteins are labeled according to their actual or potential enzyme activities by the following abbreviations: T, trypsinogen; C, chymotrypsinogen; PE, proelastase; PA, procarboxypeptidase A; A, amylase; G, glyco- (ampicillin resistance, lac-) were selected in the presence of 5-bromo-4-chloro-3-indolyl-/3D-galactoside. Colonies were transferred to microtiter dishes and grown in LB medium with ampicillin.
Characterization of cDNA Clones. Clones were screened by colony hybridization and colony identification was verified by hybrid selection/code analysis as described in the legend to Fig.  1 . Recombinant plasmid DNAs, extracted with alkaline NaDodSO4, were sized on agarose and acrylamide gels by using molecular weight markers. The nucleotide sequences of cDNA transcripts were determined by the chemical modification technique of Maxam and Gilbert (17) and the primer extension procedure of Hagenbuchle et al. (18) as modified by MacDonald et al. (19) . Translation of nucleotide sequences into amino acid sequences and identification of restriction enzyme cleavage sites were conducted using computer programs (20) .
Immunoselection of Canine Pancreatic C2 mRNA, Colony Selection by Hybridization, and Code Verification of cDNA Clones. Canine exocrine pancreatic proteins were extracted from a crude zymogen granule fraction and separated by two-dimensional IEF/NaDodSO4 gel electrophoresis as described by Came and Scheele (6) . Monospecific polyclonal antibodies were prepared by excision of chymotrypsinogen 2 spots and repeated injection of an emulsified protein/acrylamide mixture into rabbits (6) . Antiserum was applied to a protein A-Sepharose affinity column, washed extensively to remove serum RNase, and a purified immunoglobulin fraction was eluted in 0.1 M glycine (pH 3.0) (21) . Antiserum was used to isolate chymotrypsinogen 2 polysomes from canine pancreas using the procedure of Kraus and Rosenberg (21) .
RESULTS

Fig
. la shows the majority of exportable proteins in the canine pancreas as separated by two-dimensional urea IEF/NaDod-S04 gel electrophoresis. Among the serine protease zymogens, three forms of chymotrypsinogen were identified: Cl, C2, and C3. * To study the cDNA and genomic clones that code for chymotrypsinogen 2 mRNA, we excised the chymotrypsinogen 2 spot (pI = 7.1; Mr = 27,500) from two-dimensional gels, raised monospecific antibodies to this protein in rabbits, and used the IgG fraction from the antiserum to immunoselect chymotrypsinogen 2 polysomes from a canine pancreas postmitochondrial supernatant fraction. The success in the production of antibody and in the immunoselection procedure is demonstrated in Fig. lb, which shows a fluorogram of the translation products directed by the purified mRNA during in vitro protein synthesis. In addition to globin that is synthesized by the residual undegraded globin mRNA in the reticulocyte lysate, only a single product appeared, which, judged by its pI (7.1) and Mr (27,500), is chymotrypsinogen 2. Purified chymotrypsinogen 2 mRNA was used to prepare a cDNA probe for the selection of colonies containing plasmids that code for chymotrypsinogen 2 mRNA. Colony hybridization conducted on 1,000 colonies from a cDNA library revealed 22 colonies with strong hybridization signals. On the basis of insert size as determined by acrylamide gel electrophoresis, 8 colonies were selected for further study.
To verify that cDNA clones code for chymotrypsinogen 2 mRNA and that such mRNA in turn codes for a protein that could be identified as chymotrypsinogen 2 and contained the appropriate structural signals for export from the cell, we checked each of the eight cDNA clones by in vitro translation of hybridselected mRNA in the presence of microsomal membranes from canine pancreas and optimal concentrations of oxidized glutathione, separation of translation products in their nonreduced state by two-dimensional IEF/NaDodSO4 gel electrophoresis, and analysis of radioactive products by fluorography. cordingly, it was chosen for nucleotide sequence analysis. Although the sequence data revealed a large open reading frame that encoded an amino acid sequence similar to that of bovine chymotrypsinogen A, the AUG initiation codon was not identified. A Sau96I-Ava I restriction fragment was labeled at the 5' end and used as a primer for the synthesis of a singlestranded cDNA extension toward the 5' end of the mRNA. The extended fragment was isolated on an acrylamide gel, electrophoresed onto DE81 paper, and eluted into buffer containing 1 M NaCl. Sequence analysis showed, in addition to the 66-base primer, an extension that overlapped 54 bases with the 5' end of the pC2-13 cDNA and a further 14-base sequence that revealed the AUG initiation codon and 7 residues into the 5' noncoding region of the mRNA. Fig. 2 shows 882 nucleotides of canine pancreatic chymotrypsinogen 2 mRNA, including 735 nucleotides representing the amino acid coding region, 6 nucleotides in the 5' noncoding region, and 87 nucleotides including a polyadenylylation signal (A-A-U-A-A:A) in the 3' noncoding region.
DISCUSSION
Characterization of exocrine pancreatic proteins from five species [guinea pig (25) , rat (26) , rabbit (27) , dog (5), and human (28) ] by two-dimensional IEF/NaDodSO4 gel electrophoresis indicates that multiple discrete forms are generally present in each species for each of the protease zymogens: trypsinogen, chymotrypsinogen, proelastase, and procarboxypeptidase A. Each of these multiple forms is apparently derived from separate mRNA species (29) . Among the three forms of chymotrypsinogen, identified in the dog (5), form 1 shows a pI of 5.5
and an M, of 27,500 and accounts for 2.4% of the exportable protein mass, as judged by the incorporation of a mixture of 15 14C-labeled amino acids into protein contained in pancreatic slices. Form 2 shows a pI of 7.1 and an Mr of 27,500 and accounts for 4.7% of the exportable protein mass; form 3 shows a pI of 9.5 and an Mr of 27,500 and accounts for 0.4% of the exportable mass.
The importance of using techniques capable of identifying cDNA clones that code for specific secretory enzymes and their isoenzymic forms is demonstrated in the data presented in this paper. Despite the use of a cDNA probe synthesized from purified chymotrypsinogen 2 mRNA and standard hybridization conditions, colony hybridization studies identified not only chymotrypsinogen 2 clones within the cDNA library but also, in several cases, clones that represented other secretory proteins. These findings indicate the limitation in colony hybridization studies and the importance of code verification as described here. Using procedures described in the Methods and in the legend to Fig. 1 , we have verified the identification of cDNA clones that code for chymotrypsinogen 2 mRNA in a biological system that synthesizes three chymotrypsinogen forms. Separation of translation products by one-dimensional polyacrylamide gel electrophoresis in NaDodSO4 fails to distinguish among the three chymotrypsinogen forms because they show identical molecular weight values.
Previous work describing the cDNA structures coding for rat pancreatic procarboxypeptidase A (30), proelastases I and II (31) , and trypsinogen 1 (19) identified these structures in terms of the extent of their sequence identity with corresponding bovine zymogens but failed to relate individual cDNA clones to specific rat secretory proteins. Ultimately, correlations between 5' flanking sequences of genes coding for pancreatic enzymes and developmental and regulatory changes in synthetic rates for specific secretory proteins will require that such identifications be made.
The nucleotide sequence presented in Fig. 2 reveals a 1-122, 42-58, 136-201, 168-182, and 191-220,  ref. 34) .
The 18-residue amino-terminal transport peptide begins at the initiator methionine and contains 16 hydrophobic residues and two polar residues, Ser and Thr. Nine of the residues are hydrophobic amino acids containing bulky side chains (Phe, Leu, Trp). Previous amino acid sequence analysis studies on canine pancreatic prechymotrypsinogen 2 and chymotrypsinogen 2 synthesized in vitro in the absence and presence of microsomal membranes, respectively (6) , determined the site of cleavage -1I +1 of the transport peptide. This site occurs at the Gly-Cys bond shown in Fig. 2 . Despite the incomplete nature of the previously described amino acid sequence, the positions of 9 residues agree with those assigned by the nucleotide sequence analysis studies reported here. As described by Steiner and coworkers (35) and Cane and Scheele (9) , a region with a high probability of forming a ( turn occurs at or near the transport peptide cleavage site of a number of presecretory proteins. The sequence Pro-Ala-Ile-Gln at positions 4-7 in the chymotrypsinogen 2 sequence shows such probability and its existence in chymotrypsinogen A has been confirmed by x-ray crystallography (4). The importance of this ( turn is underscored by the fact that the first 13 residues, including the (3 turn region, are conserved in the three chymotrypsinogen sequences (see Fig.  3 ).
